Schizophrenia, tardive dyskinesia and essential fatty acids

Krishna S. Vaddadi, Christopher J. Gilleard, Eileen Soosai, A. K. Polonowita, Robert A. Gibson, Graham D. Burrows

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

Several reports have indicated that people suffering from schizophrenia show an associated abnormality in levels of certain essential fatty acids (EFAs) in blood cells. Similar abnormalities have also been noted in association with the presence of tardive dyskinesia (TD). In order to study this further, 72 patients with the diagnosis of schizophrenia or schizoaffective disorder were examined to assess the relationship between psychiatric status, movement disorder (TD) and relative levels of the n-3 and n-6 essential fatty acids in red blood cell membranes and plasma. Patients were followed up over the next 4.5 years to determine whether or not changes in clinical state showed any systematic relationship to changes in essential fatty acid levels. We hypothesised that patients with schizophrenia would show persistently lowered levels of n-6 and n-3 series essential fatty acids, compared with normal controls. We further hypothesised that this abnormality would be greater in the presence versus absence of TD and the dominance of negative rather than positive symptoms. The only consistent findings were that lower levels of linoleic acid and higher levels of dihomogamma-linolenic acid characterised the patient population compared with control subjects but there was considerable variability in patients' EFA profile.

LanguageEnglish
Pages287-294
Number of pages8
JournalSchizophrenia Research
Volume20
Issue number3
DOIs
Publication statusPublished - 5 Jul 1996

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Biological Psychiatry

Cite this

Vaddadi, K. S., Gilleard, C. J., Soosai, E., Polonowita, A. K., Gibson, R. A., & Burrows, G. D. (1996). Schizophrenia, tardive dyskinesia and essential fatty acids. Schizophrenia Research, 20(3), 287-294. https://doi.org/10.1016/0920-9964(95)00095-X
Vaddadi, Krishna S. ; Gilleard, Christopher J. ; Soosai, Eileen ; Polonowita, A. K. ; Gibson, Robert A. ; Burrows, Graham D. / Schizophrenia, tardive dyskinesia and essential fatty acids. In: Schizophrenia Research. 1996 ; Vol. 20, No. 3. pp. 287-294.
@article{9a82a338bd7d483a8a07df75ca4f08b6,
title = "Schizophrenia, tardive dyskinesia and essential fatty acids",
abstract = "Several reports have indicated that people suffering from schizophrenia show an associated abnormality in levels of certain essential fatty acids (EFAs) in blood cells. Similar abnormalities have also been noted in association with the presence of tardive dyskinesia (TD). In order to study this further, 72 patients with the diagnosis of schizophrenia or schizoaffective disorder were examined to assess the relationship between psychiatric status, movement disorder (TD) and relative levels of the n-3 and n-6 essential fatty acids in red blood cell membranes and plasma. Patients were followed up over the next 4.5 years to determine whether or not changes in clinical state showed any systematic relationship to changes in essential fatty acid levels. We hypothesised that patients with schizophrenia would show persistently lowered levels of n-6 and n-3 series essential fatty acids, compared with normal controls. We further hypothesised that this abnormality would be greater in the presence versus absence of TD and the dominance of negative rather than positive symptoms. The only consistent findings were that lower levels of linoleic acid and higher levels of dihomogamma-linolenic acid characterised the patient population compared with control subjects but there was considerable variability in patients' EFA profile.",
author = "Vaddadi, {Krishna S.} and Gilleard, {Christopher J.} and Eileen Soosai and Polonowita, {A. K.} and Gibson, {Robert A.} and Burrows, {Graham D.}",
year = "1996",
month = "7",
day = "5",
doi = "10.1016/0920-9964(95)00095-X",
language = "English",
volume = "20",
pages = "287--294",
journal = "Schizophrenia Research",
issn = "0920-9964",
publisher = "Elsevier",
number = "3",

}

Vaddadi, KS, Gilleard, CJ, Soosai, E, Polonowita, AK, Gibson, RA & Burrows, GD 1996, 'Schizophrenia, tardive dyskinesia and essential fatty acids', Schizophrenia Research, vol. 20, no. 3, pp. 287-294. https://doi.org/10.1016/0920-9964(95)00095-X

Schizophrenia, tardive dyskinesia and essential fatty acids. / Vaddadi, Krishna S.; Gilleard, Christopher J.; Soosai, Eileen; Polonowita, A. K.; Gibson, Robert A.; Burrows, Graham D.

In: Schizophrenia Research, Vol. 20, No. 3, 05.07.1996, p. 287-294.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Schizophrenia, tardive dyskinesia and essential fatty acids

AU - Vaddadi, Krishna S.

AU - Gilleard, Christopher J.

AU - Soosai, Eileen

AU - Polonowita, A. K.

AU - Gibson, Robert A.

AU - Burrows, Graham D.

PY - 1996/7/5

Y1 - 1996/7/5

N2 - Several reports have indicated that people suffering from schizophrenia show an associated abnormality in levels of certain essential fatty acids (EFAs) in blood cells. Similar abnormalities have also been noted in association with the presence of tardive dyskinesia (TD). In order to study this further, 72 patients with the diagnosis of schizophrenia or schizoaffective disorder were examined to assess the relationship between psychiatric status, movement disorder (TD) and relative levels of the n-3 and n-6 essential fatty acids in red blood cell membranes and plasma. Patients were followed up over the next 4.5 years to determine whether or not changes in clinical state showed any systematic relationship to changes in essential fatty acid levels. We hypothesised that patients with schizophrenia would show persistently lowered levels of n-6 and n-3 series essential fatty acids, compared with normal controls. We further hypothesised that this abnormality would be greater in the presence versus absence of TD and the dominance of negative rather than positive symptoms. The only consistent findings were that lower levels of linoleic acid and higher levels of dihomogamma-linolenic acid characterised the patient population compared with control subjects but there was considerable variability in patients' EFA profile.

AB - Several reports have indicated that people suffering from schizophrenia show an associated abnormality in levels of certain essential fatty acids (EFAs) in blood cells. Similar abnormalities have also been noted in association with the presence of tardive dyskinesia (TD). In order to study this further, 72 patients with the diagnosis of schizophrenia or schizoaffective disorder were examined to assess the relationship between psychiatric status, movement disorder (TD) and relative levels of the n-3 and n-6 essential fatty acids in red blood cell membranes and plasma. Patients were followed up over the next 4.5 years to determine whether or not changes in clinical state showed any systematic relationship to changes in essential fatty acid levels. We hypothesised that patients with schizophrenia would show persistently lowered levels of n-6 and n-3 series essential fatty acids, compared with normal controls. We further hypothesised that this abnormality would be greater in the presence versus absence of TD and the dominance of negative rather than positive symptoms. The only consistent findings were that lower levels of linoleic acid and higher levels of dihomogamma-linolenic acid characterised the patient population compared with control subjects but there was considerable variability in patients' EFA profile.

UR - http://www.scopus.com/inward/record.url?scp=0030570528&partnerID=8YFLogxK

U2 - 10.1016/0920-9964(95)00095-X

DO - 10.1016/0920-9964(95)00095-X

M3 - Article

VL - 20

SP - 287

EP - 294

JO - Schizophrenia Research

T2 - Schizophrenia Research

JF - Schizophrenia Research

SN - 0920-9964

IS - 3

ER -

Vaddadi KS, Gilleard CJ, Soosai E, Polonowita AK, Gibson RA, Burrows GD. Schizophrenia, tardive dyskinesia and essential fatty acids. Schizophrenia Research. 1996 Jul 5;20(3):287-294. https://doi.org/10.1016/0920-9964(95)00095-X